Literature DB >> 6163842

Alterations in protein synthetic capability of nerve cells in Alzheimer's disease.

D M Mann, D Neary, P O Yates, J Lincoln, J S Snowden, P Stanworth.   

Abstract

Cytoplasmic RNA content, nuclear and nucleolar volume are all significantly reduced in nerve cells of the temporal cortex in cases of Alzheimer's disease, examined both at diagnostic craniotomy and post mortem, when compared with non=demented control cases of similar age. On average, at necropsy, all three parameters are equally reduced by about 40-50%, but in biopsy cases, nuclear volume is decreased by the greatest amount (43%), followed by nucleolar volume is decreased by the greatest amount (43%), followed by nucleolar volume (36%), and cytoplasmic RNA (26%). These findings indicate that a change in protein synthesis occurs daily in the course of Alzheimer's disease which may result from a primary alteration within the nuclear apparatus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163842      PMCID: PMC490839          DOI: 10.1136/jnnp.44.2.97

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  Cytophotometric mapping of neuronal changes in senile dementia.

Authors:  D M Mann; P O Yates; C M Barton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-03       Impact factor: 10.154

2.  The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleolar volume in senile dementia.

Authors:  D M Mann; K G Sinclair
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Mar-Apr       Impact factor: 8.090

3.  Lipoprotein pigments--their relationship to ageing in the human nervous system. I. The lipofuscin content of nerve cells.

Authors:  D M Mann; P O Yates
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

4.  Chemical pathology of this organic dementias. II. Quantitative estimation of cellular changes in post-mortem brains.

Authors:  D M Bowen; C B Smith; P White; R H Flack; L H Carrasco; J L Gedye; A N Davison
Journal:  Brain       Date:  1977-09       Impact factor: 13.501

5.  Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.

Authors:  P Davies
Journal:  Brain Res       Date:  1979-08-03       Impact factor: 3.252

6.  Altered chromatin conformation in Alzheimer's disease.

Authors:  D R Crapper; S Quittkat; U de Boni
Journal:  Brain       Date:  1979-09       Impact factor: 13.501

7.  The relationship between lipofuscin pigment and ageing in the human nervous system.

Authors:  D M Mann; P O Yates; J E Stamp
Journal:  J Neurol Sci       Date:  1978-06       Impact factor: 3.181

8.  Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.

Authors:  E K Perry; P H Gibson; G Blessed; R H Perry; B E Tomlinson
Journal:  J Neurol Sci       Date:  1977-11       Impact factor: 3.181

9.  Changes in the monoamine containing neurones of the human CNS in senile dementia.

Authors:  D M Mann; J Lincoln; P O Yates; J E Stamp; S Toper
Journal:  Br J Psychiatry       Date:  1980-06       Impact factor: 9.319

10.  Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.

Authors:  N R Sims; D M Bowen; C C Smith; R H Flack; A N Davison; J S Snowden; D Neary
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

  10 in total
  18 in total

1.  Entorhinal verrucae geometry is coincident and correlates with Alzheimer's lesions: a combined neuropathology and high-resolution ex vivo MRI analysis.

Authors:  Jean C Augustinack; Kristen E Huber; Gheorghe M Postelnicu; Sita Kakunoori; Ruopeng Wang; André J W van der Kouwe; Lawrence L Wald; Thor D Stein; Matthew P Frosch; Bruce Fischl
Journal:  Acta Neuropathol       Date:  2011-12-13       Impact factor: 17.088

2.  Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.

Authors:  Miguel Angel Riudavets; Diego Iacono; Susan M Resnick; Richard O'Brien; Alan B Zonderman; Lee J Martin; Gay Rudow; Olga Pletnikova; Juan C Troncoso
Journal:  Neurobiol Aging       Date:  2007-06-28       Impact factor: 4.673

3.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

4.  Alzheimer's disease: a correlative study.

Authors:  D Neary; J S Snowden; D M Mann; D M Bowen; N R Sims; B Northen; P O Yates; A N Davison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

5.  Influence of vitamin B12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type.

Authors:  C Gomes-Trolin; C G Gottfries; B Regland; L Oreland
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Changes in the number of neurons in the mesencephalic and motor nuclei of the trigeminal nerve in the ageing mouse brain.

Authors:  R R Sturrock
Journal:  J Anat       Date:  1987-04       Impact factor: 2.610

7.  Two distinct secretory ribonucleases from human cerebrum: purification, characterization and relationships to other ribonucleases.

Authors:  T Yasuda; D Nadano; H Takeshita; K Kishi
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

8.  The noradrenergic system in Alzheimer and multi-infarct dementias.

Authors:  D M Mann; P O Yates; J Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

9.  Astrocyte RNA in relation to neuronal RNA depletion in Alzheimer's disease.

Authors:  J A Doebler; W R Markesbery; A Anthony; S W Scheff; R E Rhoads
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex.

Authors:  S B Zain; M Salim; W G Chou; E M Sajdel-Sulkowska; R E Majocha; C A Marotta
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.